Skip to main content
    S

    Sotera Health Co (SHC)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $16.25
    -0.36 (-2.17%)

    Market Cap: $4.74B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Sotera Health Co (SHC) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Sotera Health (SHC) trades at 17.1x trailing earnings and 3.8x sales. Its P/E of 17.1x is below its 5-year median of 18.9x. Its forward P/E is 16.1x. The median P/E across 8 similar companies is 33.8x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 6.2% higher over the next year. Its free cash flow yield is 2.9%.

    MultipleValue
    P/E (trailing)17.1x
    Forward P/E16.1x
    Price to sales3.8x
    Price to book6.3x
    EV/EBITDA11.8x
    Price to FCF34.3x
    EV/FCF48.0x
    PEG1.7
    FCF yield2.9%
    As of Nov 17, 2026

    Historical Medians

    MultipleCurrent5-year median10-year median
    P/E17.1x18.9xN/A
    P/S3.8x4.0xN/A
    P/B6.3x8.7xN/A
    Medians of month-end values through Oct 2026: 48 to 60 months (5-year).

    Valuation History

    Over the 6 year ends shown, its P/E ranged from 8.6x in 2022 to 227.0x in 2020.

    Year endPriceP/EP/SP/B
    2025$17.6420.5x4.3x8.3x
    2024$13.6819.5x3.5x9.6x
    2023$16.8520.8x4.5x10.8x
    2022$8.338.6xN/A6.7x
    2021$23.5526.8x7.1x11.2x
    2020$27.44227.0x8.6x15.4x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About SHC

    What is SHC's forward P/E ratio?

    Sotera Health has a forward P/E ratio of 16.1x.

    Is SHC stock overvalued?

    GNG's valuation label for SHC is Undervalued. Its P/E of 17.1x compares with a median of 33.8x across 8 similar companies.

    What is SHC's price to sales ratio?

    Sotera Health has a price to sales ratio of 3.8x.

    What is Sotera Health's average P/E ratio over 5 years?

    Sotera Health's median P/E over the last 5 years is 18.9x, from 60 month-end values through Oct 2026.

    What is SHC's PEG ratio?

    Sotera Health has a PEG ratio of 1.7.